EUVIMEDEUVIMED entdecken
Crossref

In Vitro and In Silico Assessment of Antileishmanial Potential of Novel Tri‐ and Penta‐Valent Antimony Complexes With Phenolic Ligands

Syeda Aaliya Shehzadi iD, Faiz Ahmed iD, Arshad Islam iD, Zeshan Ahmed, Khizar Abdullah, Farhan Younas, Ali Haider, Muhammad Tariq, Ahmed Noureldeen, Bander Albogami, Hadeer Darwish, Fatemah Enad M Alajmi

Drug Development Research · 2025

DOI: 10.1002/ddr.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von Syeda Aaliya Shehzadi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sulaiman Bin Abdullah Aba Al‑Khail‑Centre for Interdisciplinary Research in Basic Sciences (SA‑CIRBS), International Islamic University, Islamabad, P…. Hauptthemen laut MEDLINE: Antimony, Antiprotozoal Agents, Leishmania tropica, Phenols. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Parts of this research was funded by Taif University, Saudi Arabia, Project No. (TU-DSPP-2024-155)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis, caused by protozoan parasites of the genus Leishmania , affects nearly 12 million people annually worldwide, and has limited, highly toxic therapeutic options. This study reports the synthesis, in vitro and in silico evaluations of four novel antimony complexes ( 3a‐3d ) as potent and safe antileishmanial agents. The complexes were synthesized using Sb‐salts with different phenolic ligands and characterized by elemental analysis, FT‐IR and NMR spectroscopic techniques. Structural parameters were further evaluated via DFT studies. The antileishmanial activity of these complexes ( 3a‐3d ) was assessed in vitro against promastigote and axenic amastigote forms of Leishmania tropica , showing promising potential as antileishmanial agents. Complex 3a and 3c were particularly active, with IC 50 values of 10.8 ± 2.1 and 11.0 ± 2.0 μmol/L against promastigotes, and 20.14 ± 6.11 and 27.72 ± 0.13 μmol/L against amastigotes, respectively. Molecular docking analysis against receptor protein (PDB ID: 8FI6) from genus Leishmania revealed high binding conformations of synthesized molecules within the active cavity of the target protein. With the lowest Ki value of 1.25 and a pattern of hydrophobic π‐interactions and strong conventional hydrogen bonds, complex 3d demonstrated excellent binding affinities within the active pocket. Notably, these complexes exhibited low cytotoxicity, compared to the standard antileishmanial drugs, TA (potassium antimonyl tartrate) and AmB (Amphotericin B), with hemolysis rates of < 12% for all complexes. Our findings suggest that these complexes ( 3a‐3d ) are promising candidates for the development of new, safer antileishmanial therapies, combining potent activity against L. tropica with significantly lower cytotoxicity compared to existing treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimonyAntiprotozoal AgentsLeishmania tropicaPhenolsCoordination ComplexesMolecular Docking SimulationLigandsHumans

Stichwörter der Autor:innen

Amphotericin BLeishmaniasisantileishmanial activityantimony complexescytotoxicitymolecular docking

Substanzen

AntimonyAntiprotozoal AgentsLigandsPhenolsCoordination Complexes

Autor:innen und Institutionen

  • Sulaiman Bin Abdullah Aba Al‑Khail‑Centre for Interdisciplinary Research in Basic Sciences (SA‑CIRBS), International Islamic University, Islamabad, Pakistan.
  • Department of Chemistry, Government College University Faisalabad, Pakistan.
  • Department of Pathology, Lady Reading Hospital, Medical Teaching Institute (MTI), Peshawar, Khyber Pukhtunkhawa, Pakistan.
  • Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
  • Department of Medical Laboratory Technology, University College of Duba, University of Tabuk, Tabuk, Kingdom of Saudi Arabia.
  • Department of Biology, College of Sciences, Taif University, Taif, Saudi Arabia.

ORCID-Profile: Syeda Aaliya Shehzadi, Faiz Ahmed, Arshad Islam

Förderung

  • Parts of this research was funded by Taif University, Saudi Arabia, Project No. (TU-DSPP-2024-155).

Zitieren

APA

Shehzadi, S. A., Ahmed, F., Islam, A., Ahmed, Z., Abdullah, K., Younas, F., Haider, A., Tariq, M., Noureldeen, A., Albogami, B., Darwish, H., & Alajmi, F. E. M. (2025). In Vitro and In Silico Assessment of Antileishmanial Potential of Novel Tri‐ and Penta‐Valent Antimony Complexes With Phenolic Ligands. Drug Development Research. https://doi.org/10.1002/ddr.70067

Vancouver

Shehzadi SA, Ahmed F, Islam A, Ahmed Z, Abdullah K, Younas F, et al. In Vitro and In Silico Assessment of Antileishmanial Potential of Novel Tri‐ and Penta‐Valent Antimony Complexes With Phenolic Ligands. Drug Development Research. 2025. doi:10.1002/ddr.70067

BibTeX
@article{Shehzadi2025,
  author = {Shehzadi, Syeda Aaliya and Ahmed, Faiz and Islam, Arshad and Ahmed, Zeshan and Abdullah, Khizar and Younas, Farhan and Haider, Ali and Tariq, Muhammad and Noureldeen, Ahmed and Albogami, Bander and Darwish, Hadeer and Alajmi, Fatemah Enad M},
  title = {In Vitro and In Silico Assessment of Antileishmanial Potential of Novel Tri‐ and Penta‐Valent Antimony Complexes With Phenolic Ligands},
  journal = {Drug Development Research},
  year = {2025},
  doi = {10.1002/ddr.70067}
}
Kostenlos starten →